Urinary Transforming Growth Factor-β1 in Relation to Serum α-Fetoprotein in Hepatocellular Carcinoma

References

• Roberts AB, Sporn MB. The transforming growth factor betas. Peptide growth factors and their receptors. I, MB Sporn, AB Roberts. Springer-Verlag, HeidelbergGermany 1990; 419–72
   Google Scholar
• Roberts AB, Thompson NL, Heine U, Flanders C, Spron MB. Transforming growth factor-beta: possible roles in carcinogenesis. Br J Cancer 1988; 57: 594–600
   PubMed Web of Science ®Google Scholar
• Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995; 21: 760–6
   PubMed Web of Science ®Google Scholar
• Carr BI, Hung TH, Itakura K, Noel M, Marceau N. TGF-β gene transcription in normal and neoplastic liver growth. J Cell Biochem 1989; 39: 477–87
   PubMedGoogle Scholar
• Shirai Y, Kawata S, Ito N, Tamura S, Takaishi K, Kiso S. Elevated levels of plasma transforming growth factor-β in patients with hepatocellular carcinoma. Jpn J Cancer Res 1992; 83: 676–9
   PubMedGoogle Scholar
• Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Cancer 1994; 73: 2275–9
   PubMed Web of Science ®Google Scholar
• Ito N, Kawata S, Tamura S, Takaishi K, Yabuuchi I, Matsuda Y. Expression of transforming growth factor-beta 1 mRNA in human hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 1202–5
   PubMedGoogle Scholar
• Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S. Elevated levels of transforming growth factor-beta and its polypeptide in human hepatocellular carcinoma. Cancer Res 1991; 15: 4080–3
   Google Scholar
• Okuda K, Kondo Y. Primary carcinoma of the liver. In: Haubrich WS, Schaffner F, Berk JE, editors. Bokus gastroenterology. 5th ed. WB Saunders, Philadelphia 1995; 2444–87
   Google Scholar
• Yachin S. The immunosuppressive properties of alpha-fetoprotein: a brief overview. Ann NY Acad Sci 1983; 417: 105–7
   PubMedGoogle Scholar
• Palladino MA, Morris RE, Starnes HF, Levinson AD. The transforming growth factor-betas: a new family of immunoregulatory molecules. Ann NY Acad Sci 1991; 593: 231–42
   Google Scholar
• Nakao K, Nakata K, Mitsuoka S, Ohtsuru A, Ido A, Hatano M. Transforming growth factor β1 differentially regulates α-fetoprotein and albumin in HuH-7 human hepatoma cells. Biochem Biophys Res Commun 1991; 174: 1294–9
   PubMedGoogle Scholar
• Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 1983; 43: 403–7
   PubMedGoogle Scholar
• Sox HC, Blatt MA, Higgins MC, Marton K. Medical decision making. Butterworth & Co. Ltd, London 1989; 37–146
   Google Scholar
• Colombo M. Should patients with chronic viral hepatitis be creened for hepatocellular carcinoma. Viral Hepatitis Rev 1995; 1: 67–75
   Google Scholar
• Jeng JE, Tsai JF. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol 1991; 34: 74–7
   PubMedGoogle Scholar
• Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer 1996; 73: 1498–502
   PubMedGoogle Scholar
• Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Br J Cancer 1995; 72: 442–6
   PubMedGoogle Scholar
• Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for Chinese hepatocellular carcinoma: a case-control study. Int J Cancer 1994; 56: 619–21
   PubMedGoogle Scholar
• Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Viral 1994; 44: 92–5
   PubMedGoogle Scholar
• Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994; 14: 98–102
   PubMedGoogle Scholar
• Tsai JF, Jeng JE, Ho MS, Lin ZY, Tsai JH. Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer 1994; 69: 1157–9
   PubMedGoogle Scholar
• Tsai JF, Margolis HS, Jeng JF., Ho MS, Ko YC, Lin ZY. Association between hepatitis B and C virus infection and Chinese hepatocellular carcinoma: a case-control study. Viral hepatitis and liver disease, K Nishioka, H Suzuki, S Mishiro, T Oda. Springer-Verlag, Tokyo 1994; 697–700
   Google Scholar
• Tsai JF. Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993; 41: 296–300
   PubMed Web of Science ®Google Scholar
• Tsai JF, Jeng JF, Chang WY, Lin ZY, Tsai JH. Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroentcrol 1994; 29: 550–2
   PubMed Web of Science ®Google Scholar
• Tsai JF, Tsai JH, Chang WY. Relationship of serum α-feto protein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Gastroenterol Jpn 1990; 25: 388–03
   PubMedGoogle Scholar
• Tsai JF, Tsai JH, Chang WY, Ton TC. Elevation of circulating immune complexes and its relationship to α-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest 1991; 9: 137–43
   PubMed Web of Science ®Google Scholar
• Chuang LY. Hon WC, Yang ML, Chang CC, Tsai JF. Urinary epidermal growth factor receptor-binding growth factors in the tumors of the digestive tract. Clin Biochem 1994; 27: 485–9
   PubMedGoogle Scholar
• Maussier ML, Valenza V, Schinco Ci, Galli G. AFP, CEA, CA19–9 and TPA in hepalocellular carcinoma. Int J Biol Markers 1990; 5: 121–6
   PubMedGoogle Scholar
• Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285–93
   PubMed Web of Science ®Google Scholar